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SUMMARY
The antigenicity of the avian sarcoma virus (ASV)-coded src-gene product pp6o% which is responsible for fibroblast transformation after ASV infection, has been investigated in STU mouse fibrosarcoma celt lines and the corresponding immune response in syngeneic mice has been determined. The development of effective anti-pp6o ~ antibody titres depends on the mode and site of injection oftumour cells and parallels tumour growth. It was found that mouse immunoglobulin heavy chains are unable to serve as substrate for the protein kinase activity of pp6o~r% Therefore, an indirect protein kinase absorption (PKA) test was initiated to demonstrate recognition of the protein kinase activity associated with the src-gene product. The availability of syngeneic mice and the corresponding ASV-transformed tumour cells should facilitate studies designed to elucidate the possible relationship between the cytoplasmic pp6o ~° and ASV-induced tumour-specific surface antigens (TSSA), for example, by allowing the production of stable mouse hybridomas synthesizing antibodies specific for pp6o ~ and TSSA.
One of the best studied agents which transform normal cells are the avian sarcoma viruses (ASV). The gene responsible for neoplastic transformation of chicken embyro fibroblasts (CEF) is denoted src (for review, see Vogt, I977) . The product of the src-gene was identified using antisera from rabbits bearing tumours induced by the ASV strain, Schmidt-Ruppin D (SR-D). This molecule is a phosphoprotein with a mol. wt. of 6oooo (pp6o ~r") which exhibits an IgG-heavy chain phosphorylating activity in the immune precipitate (Brugge & Erikson, I977; Brugge et al. 1978a; Collett & Erikson, I978; Levinson et al. I978; Purchio et aL J978; Sefton et al. I978) . Conditional mutations in the src-gene affect both enzyme activity and thermal stability of pp6o "r° (Collett & Erikson, 1978; Levinson et al. t978; Riibsamen et al. r979) , providing evidence that the enzymic activity is a true function of pp6o ~r° and not a contamination in the precipitate.
In the present study we have characterized the immune reaction to pp6o 'r° in syngeneic mice bearing SR-D-derived tumours. This species is of special interest for us as we have initiated the establishment of mouse-mouse hybridomas for the production of monoclonal antibodies against pp6o "re using the method described by K6hler & Milstein (I975) . Antipp6o ~r° antisera and corresponding monoclonal antibodies will be used for elucidation of possible relationships between pp6o ~c and the tumour-specific cell surface antigen (TSSA) known to be associated with ASV-induced cell transformation (for review, see Kurth & Bauer, I975; Kurth et al. I979) .
Chicken embryo fibroblasts (CEF) were prepared from l I day-old embryos (Spafas Inc., Roanoke, Ilk, U.S.A.) and infected with the ASV strain SR-D (originally obtained from R. R. Friis, Giessen University, West Germany) or a transformation-defective (td) SR-D deletion mutant (donated by T. Graf, Max-Planck-lnstitut ffir Virusforschung, Tiibingen, West Germany). CEF infected with td SR-D virus were subcultured at least three to four oo22-I317/8o/oooo-3977 $o2.oo(~ 198o SGM times. Successful infection was repeatedly monitored by interference tests (Vogt & Ishizaki, I966) .
The ASV-transformed STU mouse cell lines DI7 (a gift from G. Pauli, Giessen University) and D56 (established by L. Netuschil, Friedrich-Miescher-Laboratorium, MaxPlanck-lnstitute) were employed as potential sources of pp6o "° from mouse cells. D17 fibrosarcoma cells are derived from an in vitro infection of STU mouse embryo fibroblasts with SR-D virus. D56 cells stem from an explanted tumour induced by SR-D virus in a newborn mouse.
Rabbit antisera against pp6o ~rc were prepared as described by Brugge & Erikson (I977) . In mice (mouse strain STU; Sch/ifer, 1979), tumours were induced either by subcutaneous injection of purified SR-D into newborns (as in rabbits) or by injection of living syngeneic SR-D-transformed mouse cells (DI7 or D56) into 6 month-old mice. Sera were collected at the times indicated in Fig. I and Table I . Antisera against ASV structural proteins were kindly prepared by J. l_6wer (Friedrich-Miescher-kaboratorium, Max-Planck-Institute).
To prepare radioactive lysates for immunoprecipitation, cells were seeded in Costar plates (Costar, Cambridge, Mass., U.S.A.) at a concentration of 5 x to ~ cells per z cm ~-well. One day later, the subconfluent cultures were starved for 3o rain in methionine-lacking medium and subsequently labelled for 2 h with ~5o /ACi 3~S-methionine (3oo to 800 Ci/ retool; Radiochemical Centre, Amersham, U.K.) per well in Eagle's medium lacking methionine and supplemented with IO°~ dialysed foetal calf serum. LabelIed cells were washed twice with normal growth medium and could be stored for lysate preparation at -7o °C for up to 4 weeks. Non-labelled cells were similarly stored without loss of ASVspecific protein kinase activity.
For pp6o To remove precursors to ASV internal core proteins, lysates were treated for 30 rain at 4 °C with anti-ASV antiserum (5 //1 of rabbit antiserum/loo/d lysate). The rabbit IgG was then precipitated with protein A-containing Staphylococcus aureus (Kessler, I975) . The absorbed lysate was clarified further by centrifugation at Iooooog for I h. For immunoprecipitation of3~S-methionine-labeIled pp6o -o, approx. 3 × 1o 6 TCA-precipitable counts of the pre-absorbed supernatant were incubated with 5 ttl of normal mouse serum or turnoutbearing mouse (TBM) serum. After I h at 4 °C, immune complexes were collected by addition of S. attreus. The resulting pellet was washed twice with buffer A and twice with buffer A containing I M-NaCt without DOC. The final pellet was suspended in sample buffer according to Laemmli (I97o). After boiling for 3 rain, the bacteria were removed by centrifugation and eluted proteins were separated on an SDS-polyacrylamide slab gel using a gradient of 7"5 to 15°<o acrylamide.
A proportion of sera from individual tumour bearing mice precipitated a 6oK protein specific for ASV-induced cell transformation from extracts of sSS-methionine-labelled, SR-D-transformed CEF (Fig. Ia) as well as of SR-D-transformed mouse cells, Dr7 or D56 (data not shown). Such immune response could be obtained from mice either inoculated as newborns with intact SR-D virus or injected as adults with live, syngeneic Dr7 (Fig. I a) or D56 tumour cells (data not shown).
As mentioned above, the protein kinase enzyme activity of the src-gene product phosphorylates in vitro the heavy chain of anti-pp6o ~o rabbit antibodies. Surprisingly, we could not detect a corresponding enzyme activity whenever mouse sera were employed to precipitate pp6o 'r° (data not shown). As S. aureus bacteria bind only certain subclasses of mouse IgG (Kronvall et al. I97o ) it was possible that these mouse immunoglobulins being able to serve as substrate for the pp6o*r°-associated protein kinase activity might have remained in the supernatant. However, using a double immunoprecipitation procedure with a rabbit antiserum specific for all mouse IgG subclasses, we were again unable to demonstrate the protein kinase activity of the pp6o "~ recognized by the TBM sera. On the other hand, phosphorylation of antipp6o~r°-specific rabbit antibodies could easily be achieved with immune complexes either bound to S. aureus (see Fig. I b) or precipitated by goat anti-rabbit IgG antiserum (not shown).
liD" " 1~ .~r_ S h o r t c o m m u n i c a t i o n s
To answer the question whether antibodies in TBM sera were either not phosphorylated by pp6o ~rc or whether they did not precipitate the pp6o~rc-associated protein kinase activity, a protein kinase absorption test (PKA test) was initiated. First, the lysates of SR-D-transformed chicken or mouse cells were incubated with the different mouse sera under study. Second, mouse IgG, to which pp6o ~r~ may have been bound, was removed using S. aureus.
The remaining supernatant was subsequently tested for residual protein kinase activity using a known anti-pp6o ~r° rabbit antiserum in the direct kinase assay.
In a typical experiment, io 7 cells were lysed with I ml of buffer B 075 mu-sodium phoso, DOC, 4o mM-NaF, I mM-PMSF, 1% Trasylol). After phate, pH 7"2, ~ °.'o, NP4o, o.I ~o clarification of the cell lysate (IOOOOOg for I h), IOO #1 lysate and Io #1 of normal or TBM serum were incubated for I h at 4 °C. After adsorption of the IgG to & aureus and sedimentation of the complexes, the remaining supernatant was reacted with 5/d of a previously characterized anti-pp6o ~'° serum from a tumour-bearing rabbit (TBR). Immune complexes were bound to S. aureus and washed as described for the precipitation of aSS-methioninelabelled pp6o -"~° using buffer B instead of A. After a final wash with kinase reaction buffer [2o mM-2(N-morpholino)ethanesulphonic acid (MES), pH 6"5, 3o mM-MgCI2] the pellet was resuspended in 20/zl of this buffer. The enzyme reaction was started by addition of 1o #1 (Io #Ci) szP-y-ATP (> zooo Ci/mmol; Radiochemical Centre, Amersham). After a I rain incubation period at room temperature the reaction was stopped by adding 3o t~l of doubleconcentrated electrophoresis sample buffer (Laemmli, I97O) followed by boiling and analysis of phosphorylated proteins on a SDS-containing Io % acrylamide slab gel. Fig. I (b) shows that the 6oK precipitating mouse sera did absorb all or most of the protein kinase activity (e.g. in tracks 3 to 6), depending on their individual titres. For the apparent inability of pp6o ~rc to phosphorylate mouse IgG, two explanations were possible: (i) the antibodies were blocking the active site of the enzyme or (ii) the mouse IgG heavy chain was not serving as a substrate for the phosphorylation by pp6o "r". We think that the latter explanation is more likely. First, among the many mouse sera tested, there should have been at least some with intermediate to low titres lacking antibodies to the active site of the enzyme, thus allowing phosphorylation of the TBM-IgG. Second, it should be kept in mind that the pp6o~r~-dependent, heavy-chain phosphorylation, although practically very useful, is biologically a highly artificial reaction. We therefore conclude that under the experimental conditions described here, mouse immunoglobulins cannot serve as acceptor for the pp6o .... mediated phosphorylation. The development of the PKA test presented in this communication circumvents this impractical property of mouse IgG.
To find an effective and reproducible immunization procedure, we looked at the differences in the immune response of individual mice. The question was whether there is any correlation between the mode of tumour induction, time of tumour development postimmunization, tumour size and antibody titres against pp6o ~r°.
Groups of ten mice were each injected in the neck with 6 × Io 5 or 6x Io 4 SR-D-transformed syngeneic mouse cells (DI7 or D56). All animals developed rapidly growing fibrosarcomas to which they succumbed after 2 to 3 weeks. However, only two of the animals developed an appreciable anti-pp6o ,'to titre (data not shown).
Other groups of mice were injected with 6 x IO 5 or 6 × Io 4 DI 7 or D56 cells into the tail. After extended latency periods of 3 to 6 weeks, tumours again developed in all cases. In this case, a positive correlation between tumour size and antibody titre could be observed. Most mice with large sarcomas (about 2 cm in diam.) developed easily demonstrable antipp6o "r° titres (Fig. I b, e.g. tracks 3 to 9, except 7). However, there were also notable exceptions, as shown, e.g., in tracks 7 and lo. The sera with lower titres (tracks I I to 16, except I3) are, on average, from mice with smaller tumours (< ~ cm in diam.).
The time course of tumour development and the corresponding anti-pp6o ~ro immune response was also correlated. Table I shows that 2 weeks after the booster of group I mice with 6 x io n cells, when the turnouts became easily visible, antibody production against pp6o ~r° started and continuous growth of the tumours was paralleled by an increase in antibody titres. Three weeks later, when the turnouts reached diam. of over 2 cm and the animals began to die, we often observed a decrease in the antibody titres. The second group showed an analogous picture (Table t) . Since the mice in this group received a booster injection of less DI7 tumour cells (6 × IOn), their tumours developed z to 3 weeks later. Consequently, their anti-pp6o ~ro immune response also developed 2 to 3 weeks later compared to group I mice. These data, taken together, suggest that the slow development of large sarcomas favours an effective anti-pp6o ~r° immune response.
We have recently obtained evidence that a proportion of the pp60"r°-specific mouse sera react with the ASV-induced tumour-specific cell-surface antigen (TSSA) in microcytotoxicity and immunofluorescence assays (T. Tanaka, J. Stegmann and R. Kurth, unpublished data). Although initially it was found that pp6o sr~ is predominantly located in the cytoplasm (Brugge et al. I978b; Rohrschneider, I979) , there is recent evidence for location of this +++ +++ * The antibody titres of individual mouse bleedings against pp6o ~c were determined by the PKA test using DI 7 cell lysates. The enzyme activity remaining in the pre-treated supernatant was determined by immunoprecipitation with anti-pp6& rc rabbit antiserum. t A booster injection was given in the third week after the first injection. :~ -, No removal of protein kinase activity from the transformed cell lysate: +, just visible removal; + +, significant removal; + + +, complete removal (compare with Fig. I b) .
§ NT, Not tested. II This mouse died.
protein at or near the plasma membrane (Willingham et al. I979)-Therefore, at least a partial expression of the pp6o =° molecule on the outer cell surface cannot yet be excluded. Establishment of hybridoma cell lines secreting antibodies against pp6o "r~ and/or TSSA can easily be monitored using the PKA test and immunofluorescence, respectively. Corresponding monoclonal antibodies should help to reveal possible antigenic and biochemical relationships between the two transformation-specific proteins.
